# Phibro Animal Health Corporation (PAHC)

> Source: Nexqual · https://nexqual.com/PAHC · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Phibro Animal Health Corporation (PAHC), nexqual.com/PAHC" · informational, not investment advice.

**Price:** USD 37.98 (+0.13% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 37.93 · day 37.83–39.64 · 52w 28.25–60.08 · market cap $1.54B · NGM

## Key facts
- Analysts: Hold (mean 3.00 on a 1–5 scale) (4 analysts), mean target USD 44 (range 35–55).
- Total return with dividends: 1Y -0.3% vs S&P 500 +18.1%; 5Y +97.3% vs S&P 500 +85.1%.
- Next earnings: 2026-11-04, EPS estimate USD 0.76, revenue estimate $382M.

## Analysts
Consensus Hold (mean 3.00 on a 1–5 scale), 4 analysts; mean target USD 44 (low 35, high 55).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -0.3% | +97.3% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -0.3% | +14.5% |
| Volatility (annualized) | 55.6% | 46.0% |
| Max drawdown | -52.1% (Apr 2026→Jun 2026) | -54.9% (Nov 2021→Nov 2023) |

## Peers (Drug Manufacturers - Specialty & Generic)
BHC (Bausch Health Companies Inc.) USD 6.31 +7.13% · HCM (HUTCHMED (China) Limited) USD 13.94 +3.26% · LQDA (Liquidia Corporation) USD 34.78 +29.73% · AMLX (Amylyx Pharmaceuticals, Inc.) USD 27.65 +2.98% · INDV (Indivior Pharmaceuticals, Inc.) USD 33.62 -5.08% · RGC (Regencell Bioscience Holdings L) USD 9.52 +16.24%

## More
Full page: https://nexqual.com/PAHC · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt